[SCHEDULE 13G/A] Corbus Pharmaceuticals Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 2 to Schedule 13G for Daily Journal Corp. (DJCO). As of the event date 06/30/2025, Vanguard reports beneficial ownership of 100,243 DJCO common shares, equal to 7.27 % of the outstanding class.

Voting power is minimal: 0 shares sole and 1,373 shares shared. Dispositive power is larger, with 97,833 shares sole and 2,410 shares shared. Vanguard files under Rule 13d-1(b) in its capacity as an investment adviser ("IA"), indicating the position is held in the ordinary course of business without the intent to influence control. The certification is signed by Ashley Grim, Head of Global Fund Administration, on 07/29/2025.

The amendment confirms Vanguard remains a >5 % passive institutional holder, providing updated ownership details but no indication of strategic changes or control ambitions.

Positive

• Vanguard Group reports ownership of 7.27 % (100,243 shares) of DJCO common stock, confirming substantial institutional interest

Negative

• None.

Insights

Securities Analyst

TL;DR – Vanguard’s passive 7.27 % stake is disclosed; limited governance or earnings impact.

The filing shows Vanguard holds just over the 5 % threshold, triggering a Schedule 13G requirement. Because the firm elects Rule 13d-1(b), the stake is passive and not activist-driven. Voting rights are negligible (only 1,373 shares), suggesting Vanguard will not materially sway shareholder votes, while sole dispositive power over ~98k shares simply reflects portfolio management flexibility. For investors, the presence of a large, reputable index manager can enhance float stability, but it does not directly affect DJCO’s operations, cash flow, or valuation multiples. Overall impact on share price or governance dynamics is expected to be neutral.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Corbus Pharmaceuticals Holdings Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

21833P301

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 21833P301

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 594,800.00
8	Shared Dispositive Power 4,695.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

599,495.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.89 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Corbus Pharmaceuticals Holdings Inc
(b)	Address of issuer's principal executive offices: 500 River Ridge Drive, Norwood, MA, 02062
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd., Malvern, PA 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 21833P301
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 599495
(b)	Percent of class: 4.89 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 594800
	(iv) Shared power to dispose or to direct the disposition of: 4695
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	07/29/2025

FAQ

How many Daily Journal Corp (DJCO) shares does Vanguard own?

The filing states Vanguard beneficially owns 100,243 shares of DJCO.

What percentage of DJCO’s outstanding shares does this represent?

Vanguard’s position equals 7.27 % of the common stock class.

Does Vanguard have significant voting power in DJCO?

No. Vanguard reports 0 sole voting power and only 1,373 shares with shared voting power.

Is Vanguard’s stake considered passive or activist?

The Schedule 13G is filed under Rule 13d-1(b) for investment advisers, indicating a passive stake.

When was the ownership information effective and filed?

The ownership is effective as of 06/30/2025; the certification was signed on 07/29/2025.